Optimize Therapy

Refine treatment of chronic inflammatory diseases with a personalized approach to therapy with biologics.

  • Individualized treatment for every patient, enabling a personalized approach to therapy with biologics
  • Early information about reduced drug efficacy - Promonitor provides an early warning if the treatment regime may require modification

Cost Effective

Reduce the use of ineffective treatment strategies, allowing a more efficient use of available resources.

  • Effectively manage resources with the information provided by Promonitor

Easy to Use

Quickly generate results with ELISA-based tests and readily available equipment.

  • Quick procedure - 4 simple steps
  • Hands-on time - 30 min
  • Microplate precoated and ready-to-use reagents
  • Easy data interpretation

Flexible

Expand lab operations and workflow with multiple tests and configurations.

  • Removable strips allow multiple configurations
  • Test both drug levels and anti-drug antibody levels
  • Manual or automated mode

High Quality

Rely on results with a high quality product.

  • High specificity and sensitivity
  • Supported by a large number of peer-reviewed articles
  • More than 100 publications using Promonitor. Download publication file

Monitoring Biosimilars

Evaluation studies have demonstrated that Promonitor kits are able to quantify not only biological drug levels, but also biosimilar drugs.

Promonitor

Promonitor IFX
Promonitor Anti-IFX
Promonitor ADL
Promonitor RTX
Promonitor Anti-RTX
Promonitor ETN
Promonitor GLM
Promonitor Anti-GLM
Promonitor Anti-ADL
Promonitor Anti-ETN
Promonitor VDZ
Promonitor Anti-VDZ
Promonitor UTK
Promonitor Anti-UTK

Related Products

Triturus ELISA instrument
Promonitor Quick IFX Test
Promonitor Quick Anti-IFX Test
Promonitor CONTROL IFX
Promonitor CONTROL ADL
Chorus Promonitor IFX
Chorus Promonitor ADL

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.